|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.296
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.290
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.235
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.217
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.195
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.182
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.178
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.175
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.173
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.143
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.143
|
|
|
|
regulation of fatty acid beta oxidation
|
GO:0031998 |
1 |
0.143
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.131
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.127
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.122
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.119
|
|
|
|
fatty acid transmembrane transport
|
GO:1902001 |
1 |
0.118
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.115
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.114
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.113
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.112
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.109
|
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.109
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.106
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.105
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.098
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.096
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.095
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.095
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.094
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.094
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.092
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.092
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.092
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.091
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.090
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.089
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.088
|
|
|
|
heparin biosynthetic process
|
GO:0030210 |
2 |
0.086
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.085
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.084
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.082
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.082
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.079
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.078
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.077
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.076
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.075
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.075
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.073
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.073
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.072
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.071
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.071
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.070
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.068
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.068
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.066
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.066
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.066
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.066
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.065
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.064
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.064
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.063
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.063
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.062
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.062
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.062
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.060
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.059
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.059
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.057
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.057
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.057
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.057
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.057
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.056
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.056
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.056
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.055
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.055
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.055
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.055
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.054
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.053
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.053
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.053
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.053
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.053
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.052
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.052
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.052
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.051
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.051
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.050
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.050
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.050
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.050
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.049
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.049
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.049
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.049
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.048
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.048
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.048
|
|
|
|
regulation of ral gtpase activity
|
GO:0032315 |
4 |
0.048
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.047
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.047
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.046
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.046
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.046
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.046
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.045
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.045
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.044
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.044
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.044
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.044
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.044
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.044
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.043
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.043
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.043
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.043
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.043
|
|
|
|
positive regulation of interleukin 5 secretion
|
GO:2000664 |
1 |
0.042
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.042
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.042
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.042
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.042
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.042
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.042
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.041
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.041
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.041
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.041
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.041
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.040
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.040
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.040
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.040
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.040
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.040
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.039
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.039
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.039
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.039
|
|
|
|
attachment of spindle microtubules to kinetochore
|
GO:0008608 |
4 |
0.039
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.039
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.039
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.039
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.038
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.038
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.038
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.038
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.038
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.038
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.037
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.037
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.037
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.037
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.037
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.037
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.037
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.037
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.037
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.036
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.036
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.036
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.036
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.036
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.036
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.036
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.036
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.035
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.035
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.035
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.035
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.035
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.035
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.035
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.035
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.035
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.035
|
|
|
|
response to uv a
|
GO:0070141 |
1 |
0.035
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.035
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.035
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.034
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.034
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.034
|
|
|
|
positive regulation of interleukin 13 secretion
|
GO:2000667 |
1 |
0.034
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.034
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.034
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.034
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.034
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.034
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.034
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.034
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.033
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.033
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.033
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.033
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.033
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.033
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.033
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.033
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.033
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.032
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.032
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.032
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.032
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.032
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.032
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.032
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.032
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.032
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.032
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.032
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.031
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.031
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.031
|
|
|
|
positive regulation of t helper 2 cell activation
|
GO:2000570 |
2 |
0.031
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.031
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.031
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.031
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.031
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.031
|
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.031
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.030
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.030
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.030
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.030
|
|
|
|
plasma membrane long chain fatty acid transport
|
GO:0015911 |
1 |
0.030
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.030
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.030
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.030
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.030
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.030
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.030
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.030
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.029
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.029
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.029
|
|
|
|
negative regulation of fatty acid oxidation
|
GO:0046322 |
5 |
0.029
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.029
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.029
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.029
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.029
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.029
|
|
|
|
proteoglycan biosynthetic process
|
GO:0030166 |
20 |
0.029
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.029
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.028
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.028
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.028
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.028
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.028
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.028
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.028
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.028
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.028
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.028
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.028
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.028
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.028
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.028
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.028
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.028
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.028
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.028
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.028
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.027
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.027
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.027
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.027
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.027
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.027
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.027
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.027
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.027
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.027
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.027
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.027
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.027
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.027
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.027
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.027
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.026
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.026
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.026
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.026
|
|
|
|
t helper 2 cell activation
|
GO:0035712 |
2 |
0.026
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.026
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.026
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.026
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.026
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.026
|
|
|
|
sensory perception of umami taste
|
GO:0050917 |
4 |
0.026
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.026
|
|
|
|
glycogen cell differentiation involved in embryonic placenta development
|
GO:0060709 |
1 |
0.025
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.025
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.025
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.025
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.025
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.025
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.025
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.025
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.025
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.025
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.025
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.025
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.025
|
|
|
|
heparin metabolic process
|
GO:0030202 |
3 |
0.025
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.025
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.024
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.024
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.023
|
|
|
|
positive regulation of protein targeting to membrane
|
GO:0090314 |
7 |
0.023
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.023
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.023
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.023
|
|
|
|
heparan sulfate proteoglycan metabolic process
|
GO:0030201 |
10 |
0.023
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.023
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
|
positive regulation of interleukin 10 secretion
|
GO:2001181 |
1 |
0.023
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.023
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.023
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.023
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.023
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.023
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.023
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.023
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.023
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.022
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.022
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.022
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.022
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.022
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.022
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.022
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.022
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.022
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.022
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.022
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.022
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.022
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.022
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.022
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.022
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.022
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.022
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.022
|
|
|
|
nucleotide sugar metabolic process
|
GO:0009225 |
4 |
0.022
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.022
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.022
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.021
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.021
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.021
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.021
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.021
|
|
|
|
trna wobble base modification
|
GO:0002097 |
2 |
0.021
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.021
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.021
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.021
|
|
|
|
regulation of ral protein signal transduction
|
GO:0032485 |
4 |
0.021
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.021
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.021
|
|
|
|
regulation of protein targeting to membrane
|
GO:0090313 |
9 |
0.021
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.020
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.020
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.020
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.020
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.020
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.020
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.020
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.020
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.020
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.020
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.020
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.020
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.020
|
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.020
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.020
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.020
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.020
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.020
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.020
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.020
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.020
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.020
|
|
|
|
fibroblast migration
|
GO:0010761 |
21 |
0.020
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.020
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.020
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.020
|
|
|
|
trna wobble uridine modification
|
GO:0002098 |
2 |
0.019
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.019
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.019
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.019
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.019
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.019
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.019
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.019
|
|
|
|
fucosylation
|
GO:0036065 |
9 |
0.019
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.019
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.019
|
|
|
|
localization within membrane
|
GO:0051668 |
4 |
0.019
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.019
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.019
|
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.019
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.019
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.019
|
|
|
|
regulation of tight junction assembly
|
GO:2000810 |
2 |
0.019
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.019
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.019
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.019
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.019
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.019
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.019
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.019
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.018
|
|
|
|
dendrite regeneration
|
GO:0031104 |
1 |
0.018
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.018
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.018
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.018
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.018
|
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.018
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.018
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.018
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.018
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.018
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.018
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.018
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.018
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.018
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.018
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.018
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.018
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.018
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.017
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.017
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.017
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.017
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.017
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.017
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.017
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.017
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.017
|
|
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
2 |
0.017
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.017
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.017
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.017
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.017
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.017
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.017
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.017
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.017
|
|
|
|
chondroitin sulfate proteoglycan biosynthetic process
|
GO:0050650 |
8 |
0.017
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.017
|
|
|
|
glycosaminoglycan biosynthetic process
|
GO:0006024 |
15 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.017
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.017
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.017
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.017
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.017
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.016
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.016
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.016
|
|
